- Analysis of 29-years of data from the Global Disease Burden 2019 study found that the incidence of stroke is declining in people ages 75 and older, yet increasing among younger and middle-aged adults (younger than 49) in certain geographic regions, particularly those who live in the South and Midwest regions of the U.S.
- Since 1990, the overall rate of people in the U.S. surviving stroke, living with stroke-related disabilities or dying from a stroke has continued to rise.
Embargoed until 4 a.m. CT/5 a.m. ET Thursday, Feb. 3, 2022
(NewMediaWire) – February 03, 2022 – NEW ORLEANS – While fewer people older than age 75 are having strokes, the incidence of stroke among adults ages 49 and younger in the U.S. has continued to increase over the last 30 years, particularly among people living in the South and Midwest regions, according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.
“Stroke is a growing public health burden in the U.S.,” said Audrey C. Leasure, B.S., lead study author and a fourth-year medical student at Yale University School of Medicine in New Haven, Connecticut. “There are about 795,000 new or recurrent strokes each year in the U.S., and the economic and health care burden of this growing population of stroke survivors has an impact on the nationwide health care infrastructure at every level.”
Using the Global Burden of Disease (GBD) 2019 study, a large-scale, peer-reviewed assessment of global trends in health, researchers evaluated U.S. stroke data from 1990 to 2019. The GBD study tracks trends for diseases and causes of death by age, sex and country. Researchers calculated stroke disability-adjusted life years, a measure of the impact of stroke on being disabled or in poor health; and yearly incidence, prevalence and death rates for all stroke and stroke subtypes, including ischemic stroke (when blood flow to the brain is blocked) and intracerebral hemorrhage (when a blood vessel in the brain bursts). They also calculated these stroke measures based on age.
The analysis found:
- Overall, in 2019 in the U.S., there were an estimated 460,000 strokes (of those, two-thirds were ischemic), 190,000 stroke-related deaths and 3.83 million stroke disability-adjusted life years.
- From 1990 to 2019, the change in the prevalence of stroke in the general population increased by about 60%. Incidence, death and disability-adjusted life years also increased by about 20%.
- However, the age-standardized rates of stroke incidence, death and disability-adjusted life years declined by 20% to-30% in that same period, and the prevalence of stroke did not change. These decreases have plateaued in the last 10 years of the study period.
- Since 1990, stroke incidence among older adults (age 50 and older) decreased nationwide, yet increased in younger adults (ages 15 to 49) in some geographic areas, including certain states in the South (Alabama, Arkansas) and the Midwest (Minnesota, North Dakota).
“Overall, these data are positive – the incidence of stroke has remained stable or declined in age-standardized measures across the U.S.,” Leasure said. “However, when we look by year, during the past five to 10 years of the study period, incidence of stroke has started to level out, and we are not seeing the same steep decrease as during the 1990s. Some of our progress in decreasing stroke incidence and death appears to be plateauing.”
According to the American Heart Association, stroke accounted for about 1 of every 19 deaths in the U.S. in 2018, and, on average, someone died of stroke every 3 minutes 33 seconds in 2016. When considered separately from other cardiovascular disease, stroke ranks No. 5 among all causes of death in the U.S. and resulted in 147,810 deaths in 2018.
The overall increase in the U.S. stroke burden may reflect an aging population and due to more people living longer after stroke than ever before. In addition, risk factors for stroke, such as high blood pressure, a leading cause of stroke, and Type 2 diabetes, are becoming more common among younger and middle-aged adults.
“Based on our findings, we hope that targeted public health interventions will be considered for younger populations particularly in the regions where stroke incidence is increasing,” Leasure said. “When we think about ways to improve these stroke numbers, we need to develop tailored interventions, because what would work for preventing stroke in older populations may not be the same in younger populations.”
Co-authors are Julian Acosta, M.D.; Richa Sharma, M.D., M.P.H.; Harlan M. Krumholz, M.D., S.M.; Adam de Havenon, M.D., M.S.C.I.; Guido J. Falcone, M.D., Sc.D., M.P.H.; and Kevin N. Sheth, M.D. The list of authors’ disclosures is available in the abstract.
No funding sources were reported for the study.
Statements and conclusions of studies that are presented at the American Stroke Association and American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.
The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
The American Stroke Association’s International Stroke Conference (ISC) is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. ISC 2022 will be held in person in New Orleans and virtually, Feb. 8-11, 2022. The three-day conference will feature more than 1,500 compelling presentations in 17 categories that emphasize basic, clinical and translational sciences as research evolves toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies. Engage in the International Stroke Conference on social media via #ISC22.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. Connect with us on stroke.org, Facebook, Twitter or by calling 1-888-4STROKE.
For Media Inquiries and AHA Expert Perspective:
AHA Communications & Media Relations in Dallas: 214-706-1173; firstname.lastname@example.org
Karen Astle: 214-706-1392; email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)